JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roman, F. J.
Right arrow Articles by Gola, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roman, F. J.
Right arrow Articles by Gola, M.

Vol. 289, Issue 3, 1391-1397, June 1999

Pharmacological Properties of Trimebutine and N-Monodesmethyltrimebutine

Francois J. Roman, Sandrine Lanet, Jacques Hamon, Gilles Brunelle, Anne Maurin, Pascal Champeroux, Serge Richard, Nicole Alessandri and Maurice Gola

Institut de Recherche Jouveinal/Parke Davis, Fresnes Cedex, France (F.J.R., S.L., J.H., G.B.); Centre de Recherches Biologiques, Chemin de Montifault, Baugy, France (A.M., P.C., S.R.); and Laboratoire de Neurobiologie, Unité Propre de Recherche, Centre National de la Recherche Scientifique, Marseille Cedex, France (N.A., M.G.)

Trimebutine [2-dimethylamino-2-phenylbutyl-3,4,5-trimethoxybenzoate hydrogen maleate (TMB)] has been demonstrated to be active for relieving abdominal pain in humans. To better understand its mechanism of action, we have tested TMB; nor-TMB, its main metabolite in humans; and their respective stereoisomers for their affinity toward sodium channels labeled by [3H]batrachotoxin, their effect on sodium, potassium, and calcium currents in rat dorsal root ganglia neurons, and their effect on veratridine-induced glutamate release from rat spinal cord slices. TMB has also been tested in an animal model of local anesthesia. TMB (Ki = 2.66 ± 0.15 µM) and nor-TMB (Ki = 0.73 ± 0.02 µM) displaced [3H]batrachotoxin from its binding site with affinities similar to that of bupivacaine (Ki = 7.1 ± 0.9 µM). nor-TMB was found to block veratridine-induced glutamate release with an IC50 value of 8.5 µM, which is very similar to that of bupivacaine (IC50 = 8.2 µM); the effect of TMB was limited to 50% inhibition at 100 µM. TMB and nor-TMB blocked sodium currents in sensory neurons from rat dorsal root ganglia (IC50 = 0.83 ± 0.09 and 1.23 ± 0.19 µM, respectively), whereas no effect was observed on calcium currents at the same concentrations. A limited effect was observed on potassium currents (IC50 = 23 ± 6 at 10 µM) for TMB. In vivo, when tested in the rabbit corneal reflex, TMB displayed a local anesthetic activity 17-fold more potent than that of lidocaine.


0022-3565/99/2893-1391$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
GutHome page
J Fioramonti and L Bueno
Centrally acting agents and visceral sensitivity
Gut, July 1, 2002; 51(90001): i91 - 95.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Bueno, J. Fioramonti, and R. Garcia-Villar
Pathobiology of Visceral Pain: Molecular Mechanisms and Therapeutic Implications: III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G670 - G676.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.